Production of Inhibin-Related Peptides by Ovarian Tumors

Autor:	Chandan J. Gurusinghe, David L. Healy, David Robertson, Tom Jobling, Nicholas Francis Cahir, Beatrice Susil, Ann E. Drummond, Anna J. Baillie, Henry G. Burger, Pamela Mamers
Rok vydání:	1997
Předmět:	Oncology Gynecology medicine.medical_specialty education.field_of_study business.industry Population Advanced stage Disease medicine.disease Malignancy Ovarian tumor Internal medicine medicine Mucinous Tumor Stage (cooking) education business Ovarian cancer
Zdroj:	Inhibin, Activin and Follistatin ISBN: 9781461273202 Monash University
DOI:	10.1007/978-1-4612-1874-6_15
Popis:	Ovarian cancer is the most common fatal gynecological malignancy, responsible for more deaths than all other forms of gynecological cancer combined. Lifetime risks for development of the disease are estimated to lie in the range of 1 in 80 to 1 in 100, with a population prevalence of approximately 30 per 100,000 women. Most patients with the disease present at an advanced stage, with 30% surviving for 5 years with a diagnosis of stage 3 epithelial malignancy (representing local and pelvic extraperitoneal spread) while only 5%–10% survive with stage 4 disease (disseminated malignancy).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85a60df9a4c65114bde231463f87ac5 https://doi.org/10.1007/978-1-4612-1874-6_15 Zobrazit plný text záznamu